Video

Komen NYC Educates Women About Breast Cancer Screening

Author(s):

Linda Tantawi, CEO of Susan G. Komen Greater New York City, discussed the organization’s events that serve as the “pink ribbon connecting the community” and some of their upcoming initiatives to help educate women about breast cancer screening and treatment.

Linda Tantawi, CEO of Susan G. Komen Greater New York City, discussed the organization’s events that serve as the “pink ribbon connecting the community” and some of their upcoming initiatives to help educate women about breast cancer screening and treatment.

Komen’s Third Annual Patient Navigation Initiative will be held June 25, which will have both lay and nurse navigators to discuss what is and isn’t working in patient navigation in the breast cancer space. The discussion will also include who is funding patient navigation, as it is currently not reimbursable through insurance.

In addition, the Sisters for the Cure event will be held on June 29. “It is our effort to really address the disparities in the African American community,” said Tantawi. “We know that African American women are 40% more likely to die from breast cancer than white women, and that is unacceptable.” This initiative will look into what can be done to ensure that African American women have the same quality and access to care as their white counterparts.

Lastly, the NY Metastatic Breast Cancer Conference will be held Oct. 5 through 6. At this event, “we bring the best researchers from all across the country right to New York (for) patients who wouldn’t have access to those researchers,” said Tantawi. “They don’t go to San Antonio, they can’t come here to ASCO, so let’s bring that information right to them.”

To learn more, visit komennyc.org.

Related Videos
Dr. Alan Tan is the GU Oncology Lead at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, as well as an associate professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center and GU Executive Officer with the Alliance for Clinical Trials in Oncology.
Bald Doctor.
Dr. Anna Arthur is the Director of the Medical Nutrition Science Program, as well as a tenure-track Assistant Professor in the Department of Dietetics and Nutrition at the University of Kansas Medical Center.
Dr. Ritu Salani, the Director of Gynecologic Oncology at the University of California, Los Angeles (UCLA), UCLA Health, and a board-certified gynecologic oncologist.
Image of Dr. Scott Kopetz
Image of Dr. Susumu Hijoka
Image of Dr. Braun.
Dr. Sattva S. Neelapu is a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine in the Department of Medicine at Beth Israel Deaconess Medical Center in Boston.